Tectonic Therapeutic, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Tectonic Therapeutic, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($19.04M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($19.98M) | Aug 7, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($19.98M) | Nov 6, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($15.91M) | Nov 6, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($15.91M) | May 8, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($15.91M) | Aug 7, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($17.72M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($12.67M) | Aug 7, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($12.67M) | Nov 6, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($15.22M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($15.22M) | May 8, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($15.22M) | Nov 6, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($10.05M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($10.46M) | Aug 14, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($10.46M) | Nov 12, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($24.96M) | May 9, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($14.45M) | Aug 14, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($14.45M) | Nov 12, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($22.97M) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($28.05M) | Aug 10, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($21.89M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($22.33M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($18.30M) | May 8, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($19.64M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($11.42M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($12.97M) | May 8, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($10.11M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($10.63M) | Aug 14, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($25.22M) | May 9, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($22.99M) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($27.77M) | Aug 10, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($29.42M) | May 11, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($32.62M) | Nov 8, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($31.38M) | Aug 9, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($26.88M) | May 10, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($36.72M) | Nov 4, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($28.86M) | Aug 5, 2021 |
| Q1 | 2021 | Mar 31, 2020 | ($26.59M) | May 13, 2021 |
| Q3 | 2020 | Sep 30, 2019 | ($18.06M) | Nov 5, 2020 |
| Q2 | 2020 | Jun 30, 2019 | ($16.61M) | Aug 6, 2020 |